MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
EBO.AX stock logo

EBO.AX

EBOS Group Limited

$17.42
0.12
 (0.69%)
[ms_data_label text=’Delayed data’]
Exchange:  ASX
Market Cap:  3.572B
Shares Outstanding:  163.711M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Distribution
   
CEO:  Adam Luke Hall
Full Time Employees:  5200
Address: 
737 Bourke Street
Docklands
VIC
3008
AU
Website:  https://www.ebosgroup.com
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue13,317,44614,411,11713,208,676.644
Gross Profit1,698,9151,784,2071,762,864.218
EBITDA630,856650,420579,907.396
Operating Income495,059527,244455,580.919
Net Income275,735296,710231,655

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets7,005,150.7237,368,948.8637,837,024.873
Total Liabilities4,498,501.4694,726,358.1734,904,078.819
Total Stockholders Equity2,649,245.8372,683,815.6182,949,891.245
Total Debt1,396,172.5971,795,195.5851,746,369.118
Cash and Cash Equivalents230,586.570236,978.802198,396.683

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow425,917.945381,312.845450,633.143
Capital Expenditure-107,032.321-92,327.360-54,253.257
Free Cash Flow318,885.623288,175.262396,379.885
Net Income276,903.77800
Net Change in Cash-332,386.5505,460.008-35,137.288

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2029Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)16,132,022.870Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)16,983,499.344Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)16,684,108.584Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)855,430.443Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)900,581.563Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)884,705.812Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)279,651.818Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)299,039.627Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)292,222.413Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)684,727.632Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)720,868.758Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)708,161.044Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)1.480Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)1.520Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)1.420Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)5Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
  ?P/S
 (TTM)
: 
0.26
?Net Income
 (TTM)
: 
  ?P/E
 (TTM)
: 
18.07
?Enterprise Value
 (TTM)
: 
6.864B  ?EV/FCF
 (TTM)
: 
82.36
?Dividend Yield
 (TTM)
: 
0.05  ?Payout Ratio
 (TTM)
: 
0.26
?ROE
 (TTM)
: 
0.08  ?ROIC
 (TTM)
: 
0.06
?Net Debt
 (TTM)
: 
  ?Debt/Equity
 (TTM)
: 
0.82
?P/B
 (TTM)
: 
1.42  ?Current Ratio
 (TTM)
: 
1.24

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
22.18Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate EBO Intrinsic Value

Common questions about EBO.AX valuation

Is EBOS Group Limited (EBO.AX) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for EBOS Group Limited (EBO.AX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is EBO.AX a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether EBO.AX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is EBO.AX’s P/E ratio?

You can see EBO.AX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for EBO.AX?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is EBO.AX a good long-term investment?

Whether EBO.AX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

EBO.AX

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

0.69
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low: 17.06   Year High: 38.23
Price Avg 50: 18.71   Price Avg 200: 24.59
Volume: 104975   Average Volume: 153674

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for EBO

Relevant news

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read